butan-2-amine), were identified after purification from dog urine. The metabolites (referred to as M2 and M5) were characterized by hydrogen/deuterium exchange MS/MS and NMR NOESY experiments as the cis and trans stereoisomers formed by cyclization of the primary amino group with the alpha carbon of the piperazine ring, following oxidative desaturation.
DMD 13128
Sitagliptin (Januvia), also known as 2, 4] triazolo [4,3-a] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine ( Fig. 1) , is a selective, potent DPP-4 inhibitor (Kim et al. 2005) , recently approved for the treatment of type 2 diabetes. Sitagliptin has been shown to inhibit plasma DPP-4 activity in normal volunteers (Bergman 2005 (Bergman , 2006 Herman et al., 2005a) and patients with type 2 diabetes (Herman 2004) , and to significantly reduce HbA 1c and fasting plasma glucose in patients with type 2 diabetes (Herman 2005b; Scott et al., 2005) . The pharmacokinetics, metabolism and excretion of sitagliptin in rats, dogs, and humans are described elsewhere Bergman et al, 2006; Vincent et al.) . The objective of the present studies was to characterize two metabolites of sitagliptin, referred to as M2 and M5. As discussed by Beconi et al. and Vincent et al., M2 and M5 were minor metabolites in vitro (rat, dog, monkey and human liver microsomes and hepatocytes) and in vivo, where they were detected at very low levels in rat and human plasma, and rat, dog and human excreta. However, M2 and M5 were relatively abundant in dog plasma, especially at the later time points, comprising 4-56% of circulating radioactivity between 1-24 hr following oral administration of [ 14 C]sitagliptin. M2 and M5 were, therefore, purified for further characterization, including evaluation of their pharmacological activity.
This article has not been copyedited and formatted. The final version may differ from this version. Phenomenex Strata-E 10-g C18 solid phase extraction cartridges using methanol as the elution solvent. The methanol extracts were evaporated to dryness, reconstituted in 10 ml water, and extracted with 40 ml of acetonitrile and ethyl acetate (1:1). The organic phase was evaporated to dryness, reconstituted in water containing 0.1% formic acid, and subjected to solid phase extraction using a Strata-E 10-g C18 cartridge, which was eluted with mixtures of 0.1% of formic acid and increasing percentage of acetonitrile. The cartridge eluates were analyzed by HPLC using a ThermoHypersil fluophase PFP analytical column, as described below, and the fractions enriched with M2 and M5 were purified on a Keystone semi-preparative HPLC column (Betasil C18, 10 x 150 mm). The M2 and M5 fractions were purified further on a ThermoHypersil fluophase PFP analytical column (4.6 x 250 mm). The mobile phase consisted of 5 mM ammonium acetate and 0.05% acetic acid in water (A) and 5 mM ammonium acetate and 0.05% acetic acid in methanol (B). The elution gradient was begun with 18% B for 2 min, increased linearly to 80% B in 33 min, and then to 95% B in 5 min, followed by a hold at 95% B This article has not been copyedited and formatted. The final version may differ from this version. 6 for 5 min. The purity of the isolated metabolites was evaluated by HPLC with UV (220 nm) and radiometric detection.
Hydrogen/Deuterium (H/D) Exchange MS/MS Experiments.
The procedure used for these experiments was as described previously (Liu et al., 2001) . Briefly, small quantities of the purified M2 and M5 were dissolved in D 2 O and then infused into a ThermoFinnigan LCQ Deca XP ion trap mass spectrometer (San Jose, CA, USA). The LCQ was operated in the electrospray positive ion mode. The source voltage was maintained at 5 kV. Data acquisition and reduction were carried out using Xcalibur software (version 1.2).
NMR Analysis. Proton and NOESY NMR spectral analyses of M2 and M5 were carried out at room temperature on a Varian Inova 600 MHz NMR spectrometer. The solvent used was deuterated methanol.
DPP-4 Activity. The purified M2 and M5 were tested for DPP-4 inhibition using a published procedure (Leiting et al., 2003) . Briefly, the metabolites were tested for inhibition of hydrolysis of 50 µM Gly-Pro-AMC (substrate) by 50 pM DPP-4 at 37°C for 30 min in a100 mM HEPES buffer (pH 7.5) in the presence of 0.1 mg/ml BSA.
This article has not been copyedited and formatted. The final version may differ from this version. could not be established. Therefore, M2 and M5 were purified from dog urine for additional mass spectrometry studies using hydrogen/deuterium exchange and NMR analysis. Following several solid-phase extractions, liquid-liquid extraction and HPLC purification steps, ~26 µg M2
and 60 µg M5 were isolated.
This article has not been copyedited and formatted. The final version may differ from this version. The hydrogen/deuterium (H/D) exchange MS/MS experiment was conducted as described previously (Liu et al., 2001) . Small quantities of the purified M2 and M5 were dissolved in D 2 O and infused into an ion trap mass spectrometer for analysis using an electrospray probe. If M2 and M5 were formed through desaturation of the carbon-carbon bond of the piperazine ring, the neutral molecules would contain two exchangeable hydrogens from the primary amino group.
On the other hand, if the primary amine had been converted to a secondary amine via C-N desaturation followed by cyclization, only one exchangeable hydrogen would be present in the neutral molecules. The experiments proved that the latter was true for both M2 and M5. The Proton NMR spectral data of sitagliptin, M2 and M5 are summarized in Table 1 . In the proton NMR spectrum of sitagliptin, the methylene f protons of the triazolopiperazine ring were observed at 4.94 and 5.02 ppm. These signals were missing from the spectra of M2 and M5, which contained, instead, a methine signal at 5.74 and 5.83 ppm, respectively. This indicated that one of the protons of the original methylene f in the parent compound had been lost. In the NOESY spectrum of M2, this isolated methine proton H f showed NOE with the g proton at 3.23 ppm, as well as the methine proton H d , where the amino group is attached. These data allowed the unambiguous assignment of the structure for M2 shown in 
